You are here

  • Home
  • Archive
  • Volume 31, Issue 12
  • Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis

Article info

Article menu

Download PDFPDF

Original research
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis
Free

Authors

  • Jennifer Chae-Kim Department of Obstetrics and Gynecology, East Carolina University Brody School of Medicine, Greenville, North Carolina, USA Department of Obstetrics and Gynecology, Baylor Scott & White Medical Center Temple, Temple, Texas, USA PubMed articlesGoogle scholar articles
  • Gunjal Garg Division of Gynecologic Oncology, East Carolina University Brody School of Medicine, Greenville, North Carolina, USA PubMed articlesGoogle scholar articles
  • Larisa Gavrilova-Jordan Division of Reproductive Endocrinology, Infertility and Genetics, Augusta University Medical College of Georgia, Augusta, Georgia, USA PubMed articlesGoogle scholar articles
  • Lindsay E Blake University of Arkansas for Medical Sciences Library, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA PubMed articlesGoogle scholar articles
  • Tongil "TI" Kim Department of Marketing, Naveen Jindal School of Management, The University of Texas at Dallas, Richardson, Texas, USA PubMed articlesGoogle scholar articles
  • Qiang Wu Department of Biostatistics, East Carolina University, Greenville, North Carolina, USA PubMed articlesGoogle scholar articles
  • Clifford C Hayslip Division of Reproductive Endocrinology and Infertility, East Carolina University Brody School of Medicine, Greenville, North Carolina, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jennifer Chae-Kim, Department of Obstetrics and Gynecology, Baylor Scott & White Medical Center Temple, Temple, Texas, USA; jennifer.chaekim{at}bswhealth.org
View Full Text

Citation

Chae-Kim J, Garg G, Gavrilova-Jordan L, et al
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis
International Journal of Gynecologic Cancer 2021;31:1499-1505.

Publication history

  • Received April 14, 2021
  • Accepted October 6, 2021
  • First published November 16, 2021.
Online issue publication 
April 26, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.